Strota / CONCORDBIO / Quarterly results

Concord Biotech Q1 FY27 Results: Revenue, Profit and Share Price Reaction

Concord Biotech's quarterly results from its filings with NSE, consolidated, with how the share price moved on each announcement.

Q1 FY27 (quarter to 30 Jun 2026): revenue ₹257 crore (+26.2% year on year), net profit ₹58.53 crore (+32.8% year on year), EPS ₹5.52. Announced 31 Jul 2026, 6:36 pm IST. The shares fell 0.44% on 3 Aug 2026, 2.04 points worse than the Nifty 50. Next results board meeting: 27 Oct 2026.
Revenue
₹257 cr
YoY +26.2% · QoQ -21.0%
Net profit
₹58.53 cr
YoY +32.8% · QoQ -34.1%
EPS (basic)
₹5.52
YoY +31.1%
Share price reaction
-0.4%
3 Aug 2026 · vs Nifty -2.0%

Revenue and net profit by quarter

RevenueNet profit
Q4 FY25 Revenue: ₹430 cr Q4 FY25 net profit: ₹140 cr Q4 FY25 Q1 FY26 Revenue: ₹204 cr Q1 FY26 net profit: ₹44.06 cr Q1 FY26 Q2 FY26 Revenue: ₹247 cr Q2 FY26 net profit: ₹63.58 cr Q2 FY26 Q3 FY26 Revenue: ₹278 cr Q3 FY26 net profit: ₹64.48 cr Q3 FY26 Q4 FY26 Revenue: ₹326 cr Q4 FY26 net profit: ₹88.79 cr Q4 FY26 Q1 FY27 Revenue: ₹257 cr Q1 FY27 net profit: ₹58.53 cr Q1 FY27

Every quarter

QuarterAnnouncedRevenueYoYNet profitYoYMarginEPSPrice reaction
Q1 FY2731 Jul 2026, 6:36 pm IST 257+26.2%58.53+32.8% 22.7%5.52 -0.4%
Q4 FY2629 May 2026, 8:22 pm IST 326-24.1%88.79-36.8% 27.2%8.46 +1.0%
Q3 FY2611 Feb 2026, 8:08 pm IST 278—64.48— 23.2%6.08 -1.3%
Q2 FY2613 Nov 2025, 7:20 pm IST 247—63.58— 25.7%6.03 +2.8%
Q1 FY268 Aug 2025, 5:01 pm IST 204—44.06— 21.6%4.21 +0.4%
Q4 FY2529 May 2025, 10:11 pm IST 430—140— 32.7%13.42 +4.9%

₹ crore. Consolidated figures; net profit is the share attributable to the company's owners where reported. Margin = net profit ÷ revenue. Year-on-year compares with the same quarter a year earlier.

How CONCORDBIO shares react to results

Across the last 6 results here, the shares rose on 4 and fell on 2. The average move was +1.22%, and the average size of the move either way 1.79%; the biggest was +4.90% after the Q4 FY25 results. In the 1 quarters where profit grew year on year, the shares rose 0 times.

The reaction is the close of the first session that could trade on the news (the announcement day if it came before 3:30 pm, otherwise the next session) against the previous close. A few results don't explain a stock's move; markets also price guidance, commentary and what was expected.

Questions

What were Concord Biotech's Q1 FY27 results?

For the quarter to 30 Jun 2026, Concord Biotech reported revenue of ₹257 crore (+26.2% year on year) and net profit of ₹59 crore (+32.8%), with basic EPS of ₹5.52.

How did Concord Biotech shares react to the Q1 results?

They fell 0.44% on 3 Aug 2026, the first session that could trade on the results (announced after the close); that was 2.04 points worse than the Nifty 50 that day.

When is Concord Biotech's next results date?

The board meets on 27 Oct 2026 to consider results, according to the company's intimation to NSE.

Do Concord Biotech shares usually rise after results?

In the last 6 results here they rose 4 times and fell 2 times, moving 1.79% on average either way.

About this data

From Concord Biotech's Integrated Filing (Financials) XBRL with NSE, which listed companies use for quarterly results since 2025; announcement times are NSE's broadcast times (IST). Share prices are NSE closing prices. See CONCORDBIO stock page for price, open interest and deals, all results declared this week and the results calendar, and CONCORDBIO dividend history.